Lupin Limited has informed the Exchange regarding a press release dated October 06, 2026, titled "Lupin Launches Formoflo-G® MDI, World s First Fixed-dose Triple Combination Drug for COPD Management".
View original source (NSE India)
Earlier from Lupin
- Lupin Receives Tentative Approval from U.S. FDA for Novel Apixaban Oral Suspension
- Lupin Limited Press Release Sep 28 2026
- Lupin Receives U.S. FDA Approval for Modafinil Tablets, USP
- Lupin and Tenpoint Therapeutics Announce Strategic Partnership to Commercialize YUVEZZI™ in the European Union, the United Kingdom, Switzerland, Norway, and Iceland